News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘BasicResearch’ clear

  • Researchers link early prostate cancer to alterations in a program controlled by a "master regulator" of cell growth. This insight could open new avenues for preventing and treating prostate cancer.

Tags: BasicResearch, ProstateCancer

  • Dana-Farber scientists and colleagues use genome- and epigenome-editing tools to pinpoint disease-causing variants.

Tags: BasicResearch, Genomics

  • Dana-Farber's David Weinstock, MD, and colleagues report that a novel compound stops B-cell acute lymphoblastic leukemia tumor cell growth in pre-clinical studies; approach may be effective in other cancers as well.

Tags: BasicResearch, Leukemia

  • The Department of Cancer Immunology and AIDS at Dana-Farber is changing its name to the Department of Cancer Immunology and Virology.

Tags: BasicResearch, Immunotherapy

  • Dana-Farber Cancer Institute and Eli Lilly and Company announced a multiyear collaboration to research new medicines under development to fight cancer.

Tags: BasicResearch, Partnerships

  • Dana-Farber's Molecular Cancer Imaging Facility in Boston's Innovation District will use cutting edge technology for research on improving cancer diagnosis and developing precision drugs matched to individual patients.

Tags: BasicResearch, Imaging

  • In a new study published in Nature, Dana-Farber scientists demonstrate how a sudden, isolated shuffling of genetic material — known as chromothripsis — can occur.

Tags: BasicResearch, Genomics

  • A new technology developed at Dana-Farber may make it possible to target "undruggable" proteins and overcome drug resistance by using a cancer cell's own protein-degrading machinery to destroy, not just inhibit, cancer proteins.

Tags: BasicResearch, TargetedTherapy

  • Dana-Farber/Brigham and Women's Cancer Center has a new website to connect patients and physicians with information about precision cancer medicine, including resources on what precision cancer is and how it can be applied to cancer care today.

Tags: BasicResearch, Genomics

  • Bruce Spiegelman, PhD, Dana-Farber Cancer Institute, has received Belgium's most important international scientific prize for his contributions to understanding the mechanisms of metabolic disorders.

Tags: BasicResearch, Honors

Showing 1-10 of 144 items